Energy Blocker Lonidamine Reverses Nimustine Resistance in Human Glioblastoma Cells through Energy Blockade, Redox Homeostasis Disruption, and O 6‑Methylguanine-DNA Methyltransferase Downregulation: In Vitro and In Vivo Validation
Article in ACS Pharmacology & Translational Science (April 2024)